Genzyme

NEXVIAZYME

Manufacturer:

Genzyme

Nexviazyme HCPCS:

J0219

HCPCS Code Descriptor:

Injection, avalglucosidase alfa-ngpt, 4 mg

Category:

J Code

Nexviazyme NDCs:

58468-0426-01

Primary Type:

Enzyme Replacement Therapy

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Nexviazyme:

NEXVIAZYME is an Enzyme Replacement Therapy drug manufactured by Genzyme and administered via the Intravenous route of administration. The J Code: J0219 is aligned to the drug NEXVIAZYME.

ACCESS PRICING AND MORE BY REGISTERING

J0219 Added Date:

April 1, 2022

J0219 Effective Date:

April 1, 2022

J0219 Termination Date:

HCPCS Active

Nexviazyme billing and coding information can be found through Genzyme at the link below:
Nexviazyme patient assistance information can be found through CareconnectPSS at the URL: https://www.careconnectpss.com/get-support
NEXVIAZYME prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for NEXVIAZYME. Please check back in a few weeks.